Evercore ISI Upgrades Spero Therapeutics (SPRO) to Outperform

September 22, 2022 4:18 PM EDT Send to a Friend
Evercore ISI analyst Josh Schimmer upgraded Spero Therapeutics (NASDAQ: SPRO) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login